Treatment with either CAPE or JSH-23 markedly abolished the promoting effect of DDX27 on cell proliferation in HCT116 cells, which was further verified in SW480 cells, suggesting that DDX27 promotes CRC growth through activating NF-кB pathway (Fig. 5b). The gene discussed is DDX27; the disease is colorectal carcinoma.